MET and adenocarcinoma: A repeat puncture biopsy of lung metastases showed adenocarcinoma, while DNA NGS (GenePlus company of Chengdu China, Gene+Seq2000, panel of 1021 genes) combined with RNA NGS (GenePlus company of Chengdu China, tumor-related RNA gene test platform) suggested CD47-MET fusion with MET p.D1228H mutation (55.1%) (Figure 2A3).